In astrocytes following in vitro ischemia, bumetanide alleviated mitochondrial dysfunction and cell death by attenuating reoxygenation-induced mitochondrial Ca2+ overload, dissipation of mitochondrial membrane potential and cytochrome c release [83,84]. Here, CYCS is linked to ischemia.